Livzon Pharmaceutical Group Inc. (000513.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Livzon Pharmaceutical Group Inc.
—
Livzon Pharmaceutical Group Inc. is led by CEO Daping Liu, employs 8,878 people, headquartered in Zhuhai, CN, publicly traded since 1993.
Livzon Pharmaceutical Group Inc. (000513.SZ) stock trades at $28.40 with a market capitalization of $23.94B. The stock is valued at a price-to-earnings (P/E) ratio of 14.26, price-to-book of 1.79, price-to-sales of 2.23. Over the past 52 weeks the stock has ranged between $25.70 and $37.85, and currently trades 25.0% below its 52-week high. It pays a dividend yielding 8.99%.
On profitability, Livzon Pharmaceutical Group Inc. generates a return on equity (ROE) of 13.42%, an operating margin of 18.52%, a net profit margin of 15.58%.
The balance sheet shows a debt-to-equity ratio of 0.24 (debt below half of shareholders' equity), a current ratio of 1.55.
000513.SZ has an average daily trading volume of 10,284,300 shares, a beta of 0.14 (historically less volatile than the overall market), 0.59B shares outstanding.
Official website: www.livzon.com.cn
Livzon Pharmaceutical Group Inc. (000513.SZ) — frequently asked questions
What is Livzon Pharmaceutical Group Inc. (000513.SZ) stock price today?
Livzon Pharmaceutical Group Inc. (000513.SZ) is currently trading at $28.40, up 4.26% today.
What is 000513.SZ P/E ratio?
Livzon Pharmaceutical Group Inc.'s P/E ratio is 14.26. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.
What is 000513.SZ return on equity (ROE)?
Livzon Pharmaceutical Group Inc.'s return on equity (ROE) is 13.42%. ROE measures net income relative to shareholders' equity. This is within the typical market range of roughly 12-15%.
What is Livzon Pharmaceutical Group Inc.'s market cap?
Livzon Pharmaceutical Group Inc. has a market capitalization of $23.94B.
Does 000513.SZ pay a dividend?
Yes. Livzon Pharmaceutical Group Inc. currently yields 8.99%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 000513.SZ carry?
Livzon Pharmaceutical Group Inc. has a debt-to-equity ratio of 0.24. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 000513.SZ's profit margin?
Livzon Pharmaceutical Group Inc. reports a net profit margin of 15.58% — the share of revenue left after every cost, including tax and interest.
What sector is 000513.SZ in?
Livzon Pharmaceutical Group Inc. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 000513.SZ listed on?
Livzon Pharmaceutical Group Inc. trades on SHZ under the ticker 000513.SZ.
What is 000513.SZ's 52-week range?
Over the last year Livzon Pharmaceutical Group Inc. has traded between $25.70 and $37.85.
Related — Stocks
Popular Stocks
Screens 000513.SZ currently matches
On the figures above, Livzon Pharmaceutical Group Inc. passes the filters for 22 of our ready-made screens, among them Undervalued Stocks, Undervalued Large Cap Stocks, Undervalued Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.